GE HealthCare Sells CodeLink Business to Applied Microarrays; GE Retains Non-Arrayed Activated Slides, Related Reagents | GenomeWeb
NEW YORK (GenomeWeb News) — Applied Microarrays has acquired GE Healthcare’s CodeLink microarrays and has been selling the tools since May 1, GenomeWeb Daily News has learned.
 
According to GE Healthcare’s Web site, as of May 1 all pre-arrayed CodeLink products, including human, mouse, and rat whole-genome arrays, will be sold through Applied Microarrays.
 
GE Healthcare will continue to sell CodeLink’s non-arrayed activated slides and related reagents, GE said.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.